Details for 2021787042

Up to date per 21.05.2026

Actions

Title / Product Name

GENETISCH VERÄNDERTE T-ZELLEN MIT REGNASE-1 UND/ODER TGFBRII-UNTERBRECHUNG MIT VERBESSERTER FUNKTIONALITÄT UND PERSISTENZ

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2021787042

EP Publication Number

4176048

E-Number

1722113

Language

PCT Number

IB21058704

Publication Date

10.05.2023 A

11.09.2024 B1

Registration Date

11.09.2024

AT Publication Date

15.10.2024

Application Date

23.09.2021

Registration Number

Priorities

23.09.2020

202063082357 P

11.12.2020

202063124429 P

26.07.2021

202163225673 P

IPC

A61K 39/00 20060101AFI20240305BHEP

Maximum Duration of Protection

23.09.2041

Owner

CRISPR Therapeutics AGBaarerstrasse 14 6300 ZugCH

Representative

No representatives present

Inventor

DEQUEANT, Mary-Lee Cambridge, Massachusetts 02139US

KALAITZIDIS, Demetrios Cambridge, Massachusetts 02139US

GHONIME, Mohammed Cambridge, Massachusetts 02139US